Calamos Advisors’s Progyny PGNY Stock Holding History

Calamos Advisors’s Portfolio PGNY Stock Details PGNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-40,000	Closed	-$679K	–	1199
2026 Q1	$679K	Buy	+40,000	New	+$858K	﹤0.01%	861
2022 Q2	–	Sell	-22,226	Closed	-$1.14M	–	1199
2022 Q1	$1.14M	Buy	+22,226	New	+$952K	﹤0.01%	993

Other funds holding PGNY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Calamos Advisors's PGNY Position: Q2 2026 in Review

Calamos Advisors sold out of Progyny (PGNY) in Q2 2026, closing a stake of 40,000 shares — an estimated $679K sold.

Calamos Advisors first reported a position in PGNY in Q1 2022 and held it in 2 quarters. The position peaked at $1.14M in Q1 2022. 311 funds tracked by Wall St. Rank hold PGNY as of Q2 2026.

Calamos Advisors reported no remaining Progyny position as of Q2 2026 after selling out during the quarter.
Calamos Advisors sold 40,000 Progyny shares in Q2 2026, an estimated $679K.
Calamos Advisors first reported a position in Progyny in Q1 2022 and held it in 2 quarters.
Calamos Advisors's Progyny position peaked at $1.14M in Q1 2022.
311 funds tracked by Wall St. Rank held Progyny as of Q2 2026.

Based on Calamos Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.